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Low plasma vitamin E levels in major depression: diet or disease? 
Abstract 
"Objective: Levels of vitamin E have been reported to be lower in patients suffering major depression, but 
whether this is due to inadequate dietary intake or the pathophysiology of depression is not known, and 
was the subject of the present study. Setting: Wollongong, Australia. Methods: Plasma vitamin E (a-
tocopherol) was measured in 49 adults with major depression, age (mean7s.d.): 47712 y. In a subset 
(n¼19) usual dietary intake of vitamin E was determined by diet history. Results: Subjects had 
significantly lower plasma a-tocopherol (4.7170.13 mmol/mmol cholesterol) than has previously been 
reported for healthy Australians, and plasma a-tocopherol was inversely related to depression score (by 
Beck Depression Inventory) (r¼ 0.367, Po0.009). Diet analysis indicated that 89% of subjects met or 
exceeded the recommended intake for vitamin E, and dietary intake was not related to plasma a-
tocopherol level in this subset. Conclusion: These findings suggest that plasma levels of a-tocopherol are 
lower in depression, but this is not likely to be the result of inability to meet recommended dietary intake." 
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INTRODUCTION 
 
Oxidative stress, an imbalance between levels of antioxidants and generation of pro-
oxidants in vivo, has been suggested to be involved in the pathophysiology of major 
depression. Depression has been reported to be associated with enhanced activation 
of the immune system (Maes, 1999) and the combination of low folate and elevated 
homocysteine levels (Bottiglieri et al., 2000) both of which may lead to or be 
associated with, a state of increased oxidative stress (Floyd et al., 1999, Huang et 
al., 2001). The association between depression and low membrane phospholipid 
content of long chain ω-3 polyunsaturated fatty acids (PUFA) (Peet et al., 1998) may 
also be suggestive of enhanced oxidative stress as long chain ω-3 PUFA are highly 
oxidisable (Song et al., 2001). 
 
Vitamin E is one of the major lipid soluble antioxidants in vivo, of which α-tocopherol 
is the dominant form (Wang & Quinn, 1999). It is a strong determinant of the 
susceptibility of low-density lipoprotein to oxidation (Esterbauer et al., 1991) and is 
one of the most important defences against membrane damage from reactive oxygen 
species (Wang & Quinn, 1999). Maes et al. (2000) reported that serum levels of α-
tocopherol were lower in 42 patients suffering from major depression compared to 
healthy controls, and suggested that this might be due to decreased antioxidant 
defenses. In a larger study of 262 elderly subjects with depressive symptoms, 
plasma α-tocopherol levels were found to be lower in males, but not females, when 
compared to healthy controls (Tiemeier et al., 2002), although the significance of this 
was abolished after controlling for nutrition-related behavioural variables. Tiemeier et 
al. (2002) suggest that the low serum α-tocopherol levels may be due to a poor diet, 
with low vitamin E intake.  The present study examined dietary vitamin E intake 
(measured as α-tocopherol equivalents) and plasma α-tocopherol levels in a group of 




The study was granted approval by the University of Wollongong Human Research 
Ethics Committee, and subjects gave written informed consent. Study subjects were 
recruited through local health services and the Northfields Clinic at the University of 
Wollongong. The major inclusion criteria were age between 18-70 years and 
currently satisfying the diagnostic criteria for major depression (American Psychiatric 
Association, 1994). Exclusion criteria were the presence of any co-existing major 
psychiatric disorder or serious medical disorder. Plasma vitamin E and cholesterol 
levels were measured in 49 subjects (29 females, 20 males), but financial limitations 
meant that dietary data is only available for the first 19 subjects enrolled (12 females 
and 7 males).  
 
Data collection and analysis 
The depression scores presented herein are those derived from administration of the 
Beck Depression Inventory (BDI). Other depression scores were measured, and the 
results of these were consistent with the BDI and are not shown. A fasted venous 
blood sample was taken into a tube containing EDTA to give a final concentration of 
1mg/ml. Plasma was separated from erythrocytes by low speed centrifugation at 
800xg, and stored at –80°C. Plasma cholesterol was determined using an enzymatic 
assay on a Cobas-Mira Plus automated analyser (Roche Diagnostics, Australia). 
Plasma α-tocopherol was determined by reverse phase high performance liquid 
chromatography (HPLC) with UV detection using a modification of a method 
described by Kock et al., (1997). There is a strong relationship between plasma 
cholesterol and α-tocopherol levels (McGavin et al., 2001), thus all results presented 
are expressed as cholesterol standardised α-tocopherol (μmol α-tocopherol / mmol 
total cholesterol). Dietary intake was assessed by a dietitian using a narrative diet 
history (Tapsell et al., 1999). Dietary histories were analysed using ESHA Food 
Processor (Version 8.0, ESHA Research, Oregon). 
 
Statistical Analyses 
Values for biochemical variables are given as mean ± SEM unless otherwise stated. 
Statistical analyses were performed on Stata version 7 (Stata Corp. TX, USA) and 
SPSS version 10 (Chicago, IL). Relationships between variables were examined 
using Spearman’s correlations and multiple regression analysis. An unpaired t-test 
was used to compare plasma α-tocopherol levels between the present study group 




The mean age of this study sample (n=49) was 47.7 ± 11.8 (Mean ± SD), comprised 
of 20 males and 29 females. Mean baseline levels for all study subjects for α-
tocopherol, depression score and total cholesterol were 4.71 ± 0.13 μmol/mmol chol, 
25.0 and  5.10 ± 0.13 mmol respectively. A significant inverse relationship was noted 
between baseline plasma α-tocopherol and depression score (r= -0.367, p=0.009). 
There was no significant difference between males and females in baseline 
depression score (M=26.4, F=24.1) or α-tocopherol (M=4.56 ± 0.19, F=4.82 ± 0.18), 
and no significant association between depression score and age (r=-0.105, 
p=0.472). However multiple regression analysis revealed that the significance of the 
association between baseline α-tocopherol and depression score abolished after 
controlling for sex and age (r=-0.268, p=0.069). Plasma α-tocopherol levels in this 
depressed population were significantly lower than has been previously reported for 
a healthy Australian population (Ward et al., 2002), (4.71± 0.13 vs 5.67 ± 0.48 
μmol/mmol chol respectively, p<0.05).   
 
Dietary analysis revealed that the Australian recommended daily intake (RDI) for 
vitamin E, namely 8mg α-tocopherol equivalents (NH&MRC, 1991), was met by 17 of 
the 19 subjects, with the mean (± SEM) intake being 25.1 ± 2.8 mg. In this subgroup, 
mean plasma α-tocopherol level was 4.91 ± 0.19 μmol/mmol chol. There was no 
correlation between plasma α-tocopherol and dietary α-tocopherol intake in the 
subgroup of subjects for whom dietary data was available.  
 
DISCUSSION 
The mean plasma level of α-tocopherol in this group of depressed subjects was 
significantly lower than has been reported previously for a non-depressed Australian 
subject group (Ward et al., 2002). In agreement with Maes et al. (2000), the present 
study found no significant effect of gender in the relationship between plasma α-
tocopherol and depression. However the significance of the association between 
depression score and α-tocopherol was diminished after controlling for age and sex. 
The Rotterdam Study, which found lower plasma α-tocopherol only in males, also 
found that the effect was abolished when other nutrition behaviour-related variables 
were taken into account (Tiemeier et al. 2002). While the sample size in the 
Rotterdam study is larger than that of the present study, it also examined an elderly 
population (mean age = 73 y). Increasing oxidative stress with post-maturational 
aging is currently a widely held theory of biological aging (Schoneich, 1999), and thus 
the age differences between these studies may be important. Another larger scale, 
longitudinal study in elderly Japanese using a condensed version of the Geriatric 
Depression Score assessment, found no relationship between serum α-tocopherol 
and depression score at baseline, but found that in men only, α-tocopherol at 
baseline was a significant predictor of progression of depressive status at a 4 year 
follow-up (Shibata et al., 1999). Conversely, levels of a marker of oxidative damage 
to DNA were found to be positively associated to depression scores in female, but 
not male, Japanese workers (Irie et al., 2002). Healthy males and premenopausal 
females have been reported to differ in their levels of lipid oxidation markers (Ide et 
al., 2002), and taken together these studies suggest that it might be important to 
consider gender in examining the relationship between depression score and 
oxidative status, however in the present study no significant effect of gender was 
discernable. 
 
The measurement of a single plasma antioxidant, as done in the present study, is 
limited in its ability to give a comprehensive indication of total oxidative stress, 
however as yet there is no gold standard measurement for oxidative stress. There is 
evidence to support the use of plasma α-tocopherol as a marker of oxidative stress, 
in an examination of the oxidative stress imposed by cigarette smoking plasma α-
tocopherol was found to be significantly negatively correlated to plasma levels of the 
lipid oxidation product malondialdehyde (Liu et al., 1998), which has previously been 
found to be higher in depressed patients than controls (Bilici et al., 2001). The 
present study is also limited by the lack of a study specific control (non-depressed) 
group, however we have no reason to suspect that residents of the Illawarra region, 
being a coastal community within 100km of Australia’s largest city, differ significantly 
in their dietary α-tocopherol (vitamin E) intake to the average Australian intake.  
 
The findings of the present study suggest that plasma cholesterol-adjusted α-
tocopherol (vitamin E) levels are lower in depression, which is in agreement with the 
findings of others (Maes et al., 2000). The adequacy of α-tocopherol intake, coupled 
with the lack of association between plasma levels and dietary intake of α-tocopherol, 
suggests that lower plasma levels of α-tocopherol are less likely to be due to poor 
diet and may be due to some other factor associated with major depression.  
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